Business Context and Reporting Period
Company: NOVAVAX INC
Filing Type: Form 8-K (Current Report)
Date of Report: September 19, 2000
Reporting Period: Event date September 19, 2000
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a change in the registrant's certifying accountant.
Material Changes
- Accountant Change: On September 19, 2000, NOVAVAX INC engaged Ernst & Young LLP as its new independent certified public accountants.
- Previous Accountant: PricewaterhouseCoopers LLP was dismissed on July 18, 2000.
- Consultation Status: The registrant did not consult with Ernst & Young LLP during the two most recent fiscal years or subsequent interim periods regarding matters subject to Statement on Auditing Standard No. 50 or any disagreements with the former accountant.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosure of the accountant change.
Investor Verification Checklist
- Verify the specific reasons for dismissing PricewaterhouseCoopers LLP on July 18, 2000.
- Confirm if there were any disagreements with the former accountant regarding accounting principles or audit scope.
- Review the transition timeline between the dismissal of the old firm and the engagement of Ernst & Young LLP.